Clinical Trials at Fletcher Allen/UVM
Clinical trials are research studies involving patients who volunteer to participate in the investigation of new therapies and medications. Clinical trials can offer patients immediate access to treatments not available anywhere else.
At Vermont's academic medical center, there are more than 1,000 currently active clinical trials across many fields of medicine.
Spotlight on Fletcher Allen Clinical Trials
Fletcher Allen researchers are investigating a new "renal denervation" procedure to treat high blood pressure for the six million Americans unresponsibe to medication blood pressure treatment. The procedure offers lasting and significant blood pressure control with a very low risk of complication.
- Learn More - contact the Department of Nephrology at (802) 847-3572 for information on the Blood Pressure clinical trial.
Fletcher Allen is one of only 45 hospitals nationally now participating in a new U.S. clinical trial to evaluate a revolutionary treatment for a common heart disease, severe aortic stenosis. These heart surgery procedures are part of a research study called TAVI (transcatheter aortic valve implantation) that is designed to determine whether this treatment can be approved for use in the U.S for treating older patients with aortic stenosis.
- Learn More - contact the Cardiology Research Office at (802) 847-4746 for information on the TAVI clinical trial.
If you would like to find out more about other open trials, please contact us or visit the Office of Clinical Trials Research or visit www.clinicaltrials.gov and search on "Vermont" to see an up to date list.
Office of Clinical Trials Research
1 South Prospect Street
Arnold Building, Level 3, Room 3437
Burlington, VT 05401